Home

irány Divatot utánzó Akinek hepatic steatosis as a marker of metabolic dysfunction Ütközés tanfolyam Erő Oroszország

Combined metabolic activators therapy ameliorates liver fat in nonalcoholic fatty  liver disease patients | Molecular Systems Biology
Combined metabolic activators therapy ameliorates liver fat in nonalcoholic fatty liver disease patients | Molecular Systems Biology

JCM | Free Full-Text | From Nonalcoholic Fatty Liver Disease (NAFLD) to Metabolic  Dysfunction-Associated Fatty Liver Disease (MAFLD)—New Terminology in  Pediatric Patients as a Step in Good Scientific Direction?
JCM | Free Full-Text | From Nonalcoholic Fatty Liver Disease (NAFLD) to Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD)—New Terminology in Pediatric Patients as a Step in Good Scientific Direction?

PDF] Nonalcoholic fatty liver disease: molecular mechanisms for the hepatic  steatosis | Semantic Scholar
PDF] Nonalcoholic fatty liver disease: molecular mechanisms for the hepatic steatosis | Semantic Scholar

CRISPR-mediated BMP9 ablation promotes liver steatosis via the  down-regulation of PPARα expression | Science Advances
CRISPR-mediated BMP9 ablation promotes liver steatosis via the down-regulation of PPARα expression | Science Advances

A problem of proportions: estimates of metabolic associated fatty liver  disease and liver fibrosis in Australian adults in the nationwide 2012  AusDiab Study | Scientific Reports
A problem of proportions: estimates of metabolic associated fatty liver disease and liver fibrosis in Australian adults in the nationwide 2012 AusDiab Study | Scientific Reports

PDF) Hepatic Steatosis as a Marker of Metabolic Dysfunction
PDF) Hepatic Steatosis as a Marker of Metabolic Dysfunction

PDF] Hepatic Steatosis as a Marker of Metabolic Dysfunction | Semantic  Scholar
PDF] Hepatic Steatosis as a Marker of Metabolic Dysfunction | Semantic Scholar

Coagulation and Endothelial Dysfunction Associated with NAFLD: Current  Status and Therapeutic Implications
Coagulation and Endothelial Dysfunction Associated with NAFLD: Current Status and Therapeutic Implications

NAFLD as a continuum: from obesity to metabolic syndrome and diabetes |  Diabetology & Metabolic Syndrome | Full Text
NAFLD as a continuum: from obesity to metabolic syndrome and diabetes | Diabetology & Metabolic Syndrome | Full Text

Livers | Free Full-Text | Oxidative Stress in Non-Alcoholic Fatty Liver  Disease
Livers | Free Full-Text | Oxidative Stress in Non-Alcoholic Fatty Liver Disease

Nonalcoholic fatty liver disease: A precursor of the metabolic syndrome -  ScienceDirect
Nonalcoholic fatty liver disease: A precursor of the metabolic syndrome - ScienceDirect

Role of hepatic fatty acid metabolism in the development of hepatic... |  Download Scientific Diagram
Role of hepatic fatty acid metabolism in the development of hepatic... | Download Scientific Diagram

Non-alcoholic fatty liver disease: the interplay between metabolism,  microbes and immunity | Nature Metabolism
Non-alcoholic fatty liver disease: the interplay between metabolism, microbes and immunity | Nature Metabolism

Association of metabolic dysfunction-associated fatty liver disease with  kidney disease | Nature Reviews Nephrology
Association of metabolic dysfunction-associated fatty liver disease with kidney disease | Nature Reviews Nephrology

Non-alcoholic fatty liver disease as a cause and a consequence of metabolic  syndrome - The Lancet Diabetes & Endocrinology
Non-alcoholic fatty liver disease as a cause and a consequence of metabolic syndrome - The Lancet Diabetes & Endocrinology

Distinct contributions of metabolic dysfunction and genetic risk factors in  the pathogenesis of non-alcoholic fatty liver disease - ScienceDirect
Distinct contributions of metabolic dysfunction and genetic risk factors in the pathogenesis of non-alcoholic fatty liver disease - ScienceDirect

Defining paediatric metabolic (dysfunction)-associated fatty liver disease:  an international expert consensus statement - The Lancet Gastroenterology &  Hepatology
Defining paediatric metabolic (dysfunction)-associated fatty liver disease: an international expert consensus statement - The Lancet Gastroenterology & Hepatology

Fatty Liver | Arteriosclerosis, Thrombosis, and Vascular Biology
Fatty Liver | Arteriosclerosis, Thrombosis, and Vascular Biology

A human pluripotent stem cell model for the analysis of metabolic  dysfunction in hepatic steatosis - ScienceDirect
A human pluripotent stem cell model for the analysis of metabolic dysfunction in hepatic steatosis - ScienceDirect

The diagnostic conundrum in non-alcoholic fatty liver disease
The diagnostic conundrum in non-alcoholic fatty liver disease

Links between metabolic syndrome and metabolic dysfunction-associated fatty  liver disease: Trends in Endocrinology & Metabolism
Links between metabolic syndrome and metabolic dysfunction-associated fatty liver disease: Trends in Endocrinology & Metabolism

Antioxidants | Free Full-Text | Mechanisms of Non-Alcoholic Fatty Liver  Disease in the Metabolic Syndrome. A Narrative Review
Antioxidants | Free Full-Text | Mechanisms of Non-Alcoholic Fatty Liver Disease in the Metabolic Syndrome. A Narrative Review

Diagnostic and interventional circulating biomarkers in nonalcoholic  steatohepatitis - Tincopa - 2020 - Endocrinology, Diabetes & Metabolism -  Wiley Online Library
Diagnostic and interventional circulating biomarkers in nonalcoholic steatohepatitis - Tincopa - 2020 - Endocrinology, Diabetes & Metabolism - Wiley Online Library

Frontiers | Non-Alcoholic Fatty Liver Disease in Obese Youth With Insulin  Resistance and Type 2 Diabetes
Frontiers | Non-Alcoholic Fatty Liver Disease in Obese Youth With Insulin Resistance and Type 2 Diabetes

Cureus | Nonalcoholic Fatty Liver Disease: An Emerging Modern-Day Risk  Factor for Cardiovascular Disease
Cureus | Nonalcoholic Fatty Liver Disease: An Emerging Modern-Day Risk Factor for Cardiovascular Disease